HIV protease inhibitor nelfinavir is a potent drug candidate against echinococcosis by targeting Ddi1-like protein

Gomez-Marin, 2014 Casulli, 2020, Recognising the substantial burden of neglected pandemics cystic and alveolar echinococcosis, Lancet Glob Health, 8, e470, 10.1016/S2214-109X(20)30066-8 Kotwa, 2019, Echinococcus multilocularis infection, Southern Ontario, Canada, Emerg Infect Dis, 25, 265, 10.3201/eid2502.180299 Paternoster, 2020, Epidemic cystic and alveolar echinococcosis in Kyrgyzstan: an analysis of national surveillance data, Lancet Glob Health, 8, e603, 10.1016/S2214-109X(20)30038-3 Torgerson, 2010, The global burden of alveolar echinococcosis, PLoS Negl Trop Dis, 4, e722, 10.1371/journal.pntd.0000722 Gottstein, 2015, Threat of alveolar echinococcosis to public health–a challenge for Europe, Trends Parasitol, 31, 407, 10.1016/j.pt.2015.06.001 Wen, 2019, Echinococcosis: advances in the 21st century, Clin Microbiol Rev, 32, 10.1128/CMR.00075-18 Torgerson, 2008, Alveolar echinococcosis: from a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years, J Hepatol, 49, 72, 10.1016/j.jhep.2008.03.023 Vuitton, 2014, Alveolar echinococcosis: evaluation of therapeutic strategies, Expert Opin Orphan Drugs, 2, 67, 10.1517/21678707.2014.870033 Roberts, 1990, Rational design of peptide-based HIV proteinase inhibitors, Science, 248, 358, 10.1126/science.2183354 Mastrolorenzo, 2007, Inhibitors of HIV-1 protease: current state of the art 10 years after their introduction. From antiretroviral drugs to antifungal, antibacterial and antitumor agents based on aspartic protease inhibitors, Curr Med Chem, 14, 2734, 10.2174/092986707782360141 Subeha, 2020, The anti-cancer properties of the HIV protease inhibitor nelfinavir, Cancers, 12, 10.3390/cancers12113437 Ohashi, 2021, Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment, iScience, 24, 10.1016/j.isci.2021.102367 Alfonso, 2011, HIV protease inhibitors: effect on the opportunistic protozoan parasites, Open Med Chem J, 5, 40, 10.2174/1874104501105010040 Wang, 2016, Comparative genomics reveals adaptive evolution of Asian tapeworm in switching to a new intermediate host, Nat Commun, 7, 12845, 10.1038/ncomms12845 Wang, 2015, Comparative genomic analysis of aspartic proteases in eight parasitic platyhelminths: insights into functions and evolution, Gene, 559, 52, 10.1016/j.gene.2015.01.020 Guo, 2017, Suppression of nemo-like kinase by miR-71 in Echinococcus multilocularis, Exp Parasitol, 183, 1, 10.1016/j.exppara.2017.10.004 Spiliotis, 2009, Axenic in vitro cultivation of Echinococcus multilocularis metacestode vesicles and the generation of primary cell cultures, Methods Mol Biol, 470, 245, 10.1007/978-1-59745-204-5_17 Fabbri, 2019, Comparison of different staining methods for determination of viability on Mesocestoides vogae tetrathyridia, Parasitol Res, 118, 687, 10.1007/s00436-018-6143-9 Stadelmann, 2010, Application of an in vitro drug screening assay based on the release of phosphoglucose isomerase to determine the structure-activity relationship of thiazolides against Echinococcus multilocularis metacestodes, J Antimicrob Chemother, 65, 512, 10.1093/jac/dkp490 Reuter, 2006, In vitro activities of itraconazole, methiazole, and nitazoxanide versus Echinococcus multilocularis larvae, Antimicrob Agents Chemother, 50, 2966, 10.1128/AAC.00476-06 Kim, 2019, Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype, Nat Biotechnol, 37, 907, 10.1038/s41587-019-0201-4 Love, 2014, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, Genome Biol, 15, 550, 10.1186/s13059-014-0550-8 Subramanian, 2005, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc Natl Acad Sci USA, 102, 15545, 10.1073/pnas.0506580102 Delano WL. PyMOL: an open-source molecular graphics tool, CCP4 Newsl. Protein Crystallogr. 2002;40(1):82–92. Mizukami, 2010, Gene silencing in Echinococcus multilocularis protoscoleces using RNA interference, Parasitol Int, 59, 647, 10.1016/j.parint.2010.08.010 Mousavi, 2020, Biological and morphological consequences of dsRNA-induced suppression of tetraspanin mRNA in developmental stages of Echinococcus granulosus, Parasit Vectors, 13, 190, 10.1186/s13071-020-04052-y Perteguer, 2013, Ddi1-like protein from Leishmania major is an active aspartyl proteinase, Cell Stress Chaperones, 18, 171, 10.1007/s12192-012-0368-9 Onchieku, 2021, Artemisinin binds and inhibits the activity of plasmodium falciparum Ddi1, a retroviral aspartyl protease, Pathogens, 10, 10.3390/pathogens10111465 Cosenza-Contreras, 2018, The Schistosomiasis SpleenOME: unveiling the proteomic landscape of splenomegaly using label-free mass spectrometry, Front Immunol, 9, 3137, 10.3389/fimmu.2018.03137 von Braun, 2019, Schistosoma and other relevant helminth infections in HIV-positive individuals-an overview, Trop Med Infect Dis, 4 Wang, 2020, Short communication: efficacy of albendazole in Echinococcus multilocularis-infected mice depends on the functional immunity of the host, Exp Parasitol, 219, 10.1016/j.exppara.2020.108013 Dumitru, 2015, Cystic Echinococcosis in HIV infected patients Lehrbach, 2016, Proteasome dysfunction triggers activation of SKN-1A/Nrf1 by the aspartic protease DDI-1, Elife, 5, 10.7554/eLife.17721 White, 2011, HIV proteinase inhibitors target the Ddi1-like protein of Leishmania parasites, FASEB J, 25, 1729, 10.1096/fj.10-178947 Gabriely, 2008, Different domains of the UBL-UBA ubiquitin receptor, Ddi1/Vsm1, are involved in its multiple cellular roles, Mol Biol Cell, 19, 3625, 10.1091/mbc.e07-05-0462 Yip, 2020, Ddi1 is a ubiquitin-dependent protease, Proc Natl Acad Sci USA, 117, 7776, 10.1073/pnas.1902298117 Wallet, 2012, The HIV-1 protease inhibitor nelfinavir activates PP2 and inhibits MAPK signaling in macrophages: a pathway to reduce inflammation, J Leukoc Biol, 92, 795, 10.1189/jlb.0911447 Evans, 2017, Tropical parasitic infections in individuals infected with HIV, Curr Trop Med Rep, 4, 268, 10.1007/s40475-017-0130-6 Adeleke, 2015, Intestinal helminth infections amongst HIV-infected adults in Mthatha General Hospital, South Africa, Afr J Prim Health Care Fam Med, 7, 910, 10.4102/phcfm.v7i1.910 Gatti, 2003, Pharmacokinetics and pharmacodynamics of nelfinavir administered twice or thrice daily to human immunodeficiency virus type 1-infected children, Clin Infect Dis, 36, 1476, 10.1086/375062 al Nahhas, 1991, In vivo cultivation of Echinococcus multilocularis protoscoleces in micropore chambers, Int J Parasitol, 21, 383, 10.1016/0020-7519(91)90046-A Borkow, 2006, HIV and helminth co-infection: is deworming necessary?, Parasite Immunol, 28, 605, 10.1111/j.1365-3024.2006.00918.x Rogan, 1998, T-cell activity associated with secondary infections and implanted cysts of Echinococcus granulosus in BALB/c mice, Parasite Immunol, 20, 527, 10.1046/j.1365-3024.1998.00180.x Zhang, 2005, Echinococcus granulosus: pre-culture of protoscoleces in vitro significantly increases development and viability of secondary hydatid cysts in mice, Exp Parasitol, 110, 88, 10.1016/j.exppara.2005.02.003 Sha, 2014, Proteasome-mediated processing of Nrf1 is essential for coordinate induction of all proteasome subunits and p97, Curr Biol, 24, 1573, 10.1016/j.cub.2014.06.004 Bachur, 2008, Enteric parasitic infections in HIV/AIDS patients before and after the highly active antiretroviral therapy, Braz J Infect Dis, 12, 115, 10.1590/S1413-86702008000200004 Fassmannova, 2020, Nelfinavir inhibits the TCF11/Nrf1-mediated proteasome recovery pathway in multiple myeloma, Cancers, 12, 10.3390/cancers12051065 Gu, 2020, Nelfinavir inhibits human DDI2 and potentiates cytotoxicity of proteasome inhibitors, Cell Signal, 75, 10.1016/j.cellsig.2020.109775 Jarvis, 1998, Nelfinavir. A review of its therapeutic efficacy in HIV infection, Drugs, 56, 147, 10.2165/00003495-199856010-00013